Perfil
Mr. Edwin Elmhirst is a Data Journalist at Evaluate Ltd.
He is responsible for a variety of behind-the-scenes functions that go into the day-to-day running of Evaluate Vantage, including data handling and analysis.
He also has prior freelance experience in editing scientific publications.
He has under- and postgraduate degrees in biomedical science.
Cargos activos de Edwin Elmhirst
Empresas | Cargo | Inicio |
---|---|---|
Evaluate Ltd.
Evaluate Ltd. Investment ManagersFinance Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021. | Corporate Officer/Principal | 01/03/2015 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Evaluate Ltd.
Evaluate Ltd. Investment ManagersFinance Part of Citeline, Inc., Evaluate Ltd. is a British company that provides trusted commercial intelligence and predictive analytics for the pharmaceutical industry and their advisors. The company is based in London, UK. Evaluate offers unique and dynamic insights into pharma asset risk and commercial potential alongside a comprehensive view of the pharmaceutical market landscape through their Evaluate Omnium and Evaluate Pharma platforms. The company's award-winning editorial team, Evaluate Vantage, provides thought-provoking news and insights into current and future industry developments. Evaluate has been a partner to industry-leading organizations for over 20 years. The company was founded in 1996. Deborah Karen Kobewka has been the CEO of the company since 2019. Evaluate was acquired by Managed Markets Insight & Technology LLC, part of Citeline, Inc. from November 01, 2022 on August 20, 2021. | Finance |
- Bolsa de valores
- Insiders
- Edwin Elmhirst